Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP338178.RA41hgaCJUjfFSmkEGZUL9_HePT7insWATl-OsE0RogZM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP338178.RA41hgaCJUjfFSmkEGZUL9_HePT7insWATl-OsE0RogZM130_assertion type Assertion NP338178.RA41hgaCJUjfFSmkEGZUL9_HePT7insWATl-OsE0RogZM130_head.
- NP338178.RA41hgaCJUjfFSmkEGZUL9_HePT7insWATl-OsE0RogZM130_assertion description "[Here, we demonstrate that serum p110 sErbB1 levels are significantly lower in EOC patients with stage III or IV disease prior to (P < 0.0001) and shortly after (P < 0.0001) cytoreductive staging laparotomy than in healthy women of similar ages, whereas EGF levels are significantly higher than those of age-matched healthy women only in serum samples collected shortly after tumor debulking surgery (P < 0.0001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP338178.RA41hgaCJUjfFSmkEGZUL9_HePT7insWATl-OsE0RogZM130_provenance.
- NP338178.RA41hgaCJUjfFSmkEGZUL9_HePT7insWATl-OsE0RogZM130_assertion evidence source_evidence_literature NP338178.RA41hgaCJUjfFSmkEGZUL9_HePT7insWATl-OsE0RogZM130_provenance.
- NP338178.RA41hgaCJUjfFSmkEGZUL9_HePT7insWATl-OsE0RogZM130_assertion SIO_000772 10067810 NP338178.RA41hgaCJUjfFSmkEGZUL9_HePT7insWATl-OsE0RogZM130_provenance.
- NP338178.RA41hgaCJUjfFSmkEGZUL9_HePT7insWATl-OsE0RogZM130_assertion wasDerivedFrom befree-20150227 NP338178.RA41hgaCJUjfFSmkEGZUL9_HePT7insWATl-OsE0RogZM130_provenance.
- NP338178.RA41hgaCJUjfFSmkEGZUL9_HePT7insWATl-OsE0RogZM130_assertion wasGeneratedBy ECO_0000203 NP338178.RA41hgaCJUjfFSmkEGZUL9_HePT7insWATl-OsE0RogZM130_provenance.